Abstract:Background Microbleeds (CMBs) serve as neuroimaging biomarkers to assess risk of intracerebral hemorrhage and diagnose cerebral small vessel disease (CSVD). Therefore, detecting CMBs can evaluate the risk of intracerebral hemorrhage and use its presence to support CSVD classification, both are conducive to optimizing CSVD management. This study aimed to develop and test a deep learning (DL) model based on susceptibility-weighted MR sequence (SWS) to detect CMBs and classify CSVD to assist neurologists in optimizing CSVD management. Methods Patients with arteriolosclerosis (aSVD), cerebral amyloid angiopathy (CAA), and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) treated at three centers were enrolled between January 2017 and May 2022 in this retrospective study. The SWSs of patients from two centers were used as the development set, and the SWSs of patients from the remaining center were used as the external test set. The DL model contains a Mask R-CNN for detecting CMBs and a multi-instance learning (MIL) network for classifying CSVD. The metrics for model performance included intersection over union (IoU), Dice score, recall, confusion matrices, receiver operating characteristic curve (ROC) analysis, accuracy, precision, and F1-score. Results A total of 364 SWS were recruited, including 336 in the development set and 28 in the external test set. IoU for the model was 0.523 ± 0.319, Dice score 0.627 ± 0.296, and recall 0.706 ± 0.365 for CMBs detection in the external test set. For CSVD classification, the model achieved a weighted-average AUC of 0.908 (95% CI: 0.895-0.921), accuracy of 0.819 (95% CI: 0.768-0.870), weighted-average precision of 0.864 (95% CI: 0.831-0.897), and weighted-average F1-score of 0.829 (95% CI: 0.782-0.876) in the external set, outperforming the performance of the neurologist group. Conclusion The DL model based on SWS can detect CMBs and classify CSVD, thereby assisting neurologists in optimizing CSVD management. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial This study was conducted following the Declaration of Helsinki. Requirements for informed consent were waived because of the study's retrospective nature. ### Funding Statement This work was supported by the National Natural Science Foundation of China (Grant No. 81971110 and 82171307), the Key Areas R&D Program of Science and Technology Program of Guangzhou (Grant No. 202206060001), the Science and Technology Program of Guangzhou (Grant No. 202007030010), and the High-level Hospital Construction Research Project of Maoming People's Hospital, the Science and Technology Special Fund Program of Maoming (Grant No. 2020KJZX006). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Medical Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The Medical Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University approved this retrospective multicenter study. <https://github.com/Huatsing-Lau/CSVD-CMBs-Detection-and-Classification.git> * CMBs : microbleeds CSVD : cerebral small vessel disease DL : deep learning SWS : susceptibility-weighted MR sequence aSVD : arteriolosclerosis CAA : cerebral amyloid angiopathy CADASIL : cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy MIL : multi-instance learning IoU : intersection over union ROC : receiver operating characteristic curve AUC : area under receiver operating characteristic curve SWAN : T2-star-weighted angiography SWI : susceptibility-weighted imaging STRIVE : STandards for ReportIng Vascular changes on nEurouimaging SYSUTH : Third Affiliated Hospital, Sun Yat-sen University (SYSUTH) MMPH : Maoming People’s Hospital STUMFH : First Affiliated Hospital of SHANTOU University Medical College SD : standard deviation Grad-CAM : Gradient-weighted Class Activation Mapping CI : confidence interval 3D-CNN : three-dimensional convolutional neural network 2D-CNN : two-dimensional convolutional neural network

Cerebral Microbleed Automatic Detection System Based on the “Deep Learning”

Cerebral microbleed detection using Susceptibility Weighted Imaging and deep learning

Deep learning based on susceptibility-weighted MR sequence for detecting cerebral microbleeds and classifying cerebral small vessel disease

Detection of Cerebral Microbleeding Based on Deep Convolutional Neural Network

CMB-HUNT: Automatic Detection of Cerebral Microbleeds Using a Deep Neural Network.

Automatic detection of cerebral micro-bleed in SWI images based on 3D CNN

Abstract T P32: Computer Aided Detection of Asymptomatic Cerebral Microbleeds on Magnetic Resonance Images

Primary Categorizing and Masking Cerebral Small Vessel Disease Based on "deep Learning System".

Automatic Cerebral Microbleeds Detection from MR Images Via Independent Subspace Analysis Based Hierarchical Features

Automated quantification of cerebral microbleeds in susceptibility-weighted MRI: association with vascular risk factors, white matter hyperintensity burden, and cognitive function

DEEPMIR: a deep neural network for differential detection of cerebral microbleeds and iron deposits in MRI

Deep Learning using Susceptibility-Weighted MR Sequence to Detect Microbleeds and Classify Cerebral Small Vessel Disease

A Comprehensive Analysis of Deep Neural-Based Cerebral Microbleeds Detection System

Automatic Detection of Cerebral Microbleeds from MR Images Via 3D Convolutional Neural Networks

Toward Automated Detection of Microbleeds with Anatomical Scale Localization: A Complete Clinical Diagnosis Support Using Deep Learning

Construction of a Medical Micro-Object Cascade Network for Automated Segmentation of Cerebral Microbleeds in Susceptibility Weighted Imaging

Segmentation of Cerebral Small Vessel Diseases-White Matter Hyperintensities Based on a Deep Learning System

CMB-net: a deep convolutional neural network for diagnosis of cerebral microbleeds

Detecting Cerebral Microbleeds Via Deep Learning with Features Enhancement by Reusing Ground Truth.

Cerebral Microbleed Detection via Convolutional Neural Network and Extreme Learning Machine

Deep Learning-Based Assessment of Cerebral Microbleeds in COVID-19